MTOR and Alzheimer disease: Conversely, suppressed mTOR signaling by rapamycin could increase pro‐inflammatory cytokines including IL‐6 and tumor necrosis factor‐α (TNF‐α) signaling pathways, as well as caspase‐3, and worsen learning performance in AD rats.